On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.02 USD | +2.28% | +3.28% | -18.50% |
07:39pm | Bristol-Myers Squibb Says Breyanzi Studies Show 'Meaningful' Outcomes Across B-cell Malignancies | MT |
02:58pm | Bristol Myers: presents advances in lung cancer | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.50% | 83.29B | |
+42.29% | 739B | |
+32.34% | 598B | |
-5.77% | 353B | |
+17.63% | 318B | |
+3.30% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.47% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company